Healthcare provider profile · identity verified

David John Nitti, MD

Internal Medicine · HAWTHORNE, NJ · NPI 1750499158

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	544	133
Amlodipine Besylate	Amlodipine Besylate	363	86
Levothyroxine Sodium	Levothyroxine Sodium	340	81
Losartan Potassium	Losartan Potassium	333	81
Alprazolam	Alprazolam	283	64
Furosemide	Furosemide	225	52
Escitalopram Oxalate	Escitalopram Oxalate	215	37
Hydrochlorothiazide	Hydrochlorothiazide	199	45
Rosuvastatin Calcium	Rosuvastatin Calcium	183	48
Omeprazole	Omeprazole	181	37
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	156	44
Pantoprazole Sodium	Pantoprazole Sodium	156	38
Eliquis	Apixaban	154	31
Meloxicam	Meloxicam	153	55
Simvastatin	Simvastatin	152	35
Tamsulosin Hcl	Tamsulosin Hcl	147	41
Metoprolol Succinate	Metoprolol Succinate	144	45
Potassium Chloride	Potassium Chloride	143	31
Metformin Hcl	Metformin Hcl	133	26
Gabapentin	Gabapentin	117	21
Prednisone	Prednisone	117	75
Metformin Hcl Er	Metformin Hcl	112	28
Metoprolol Tartrate	Metoprolol Tartrate	112	19
Atenolol	Atenolol	110	26
Zolpidem Tartrate	Zolpidem Tartrate	107	19
Sertraline Hcl	Sertraline Hcl	105	28
Lisinopril	Lisinopril	101	28
Memantine Hcl	Memantine Hcl	101	11
Donepezil Hcl	Donepezil Hcl	90	14
Torsemide	Torsemide	83	15
Famotidine	Famotidine	81	13
Hydralazine Hcl	Hydralazine Hcl	79	17
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	74	20
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	72	19
Glimepiride	Glimepiride	71	20
Clopidogrel	Clopidogrel Bisulfate	70	14
Mirtazapine	Mirtazapine	66	11
Montelukast Sodium	Montelukast Sodium	66	15
Pravastatin Sodium	Pravastatin Sodium	64	20
Finasteride	Finasteride	59	suppressed
Fluticasone Propionate	Fluticasone Propionate	59	16
Ezetimibe	Ezetimibe	58	suppressed
Bupropion Xl	Bupropion Hcl	56	11
Albuterol Sulfate Hfa	Albuterol Sulfate	51	14
Pregabalin	Pregabalin	51	suppressed
Lorazepam	Lorazepam	50	12
Ramipril	Ramipril	47	12
Valsartan	Valsartan	47	12
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	46	12
Olmesartan Medoxomil	Olmesartan Medoxomil	46	suppressed
Levofloxacin	Levofloxacin	44	39
Oxybutynin Chloride Er	Oxybutynin Chloride	44	suppressed
Rybelsus	Semaglutide	44	suppressed
Enalapril Maleate	Enalapril Maleate	43	suppressed
Tramadol Hcl	Tramadol Hcl	43	22
Trazodone Hcl	Trazodone Hcl	43	suppressed
Cefuroxime	Cefuroxime Axetil	42	37
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	42	suppressed
Farxiga	Dapagliflozin Propanediol	40	suppressed
Latanoprost	Latanoprost	40	suppressed
Clonazepam	Clonazepam	39	suppressed
Jardiance	Empagliflozin	39	suppressed
Meclizine Hcl	Meclizine Hcl	39	18
Spironolactone	Spironolactone	37	suppressed
Duloxetine Hcl	Duloxetine Hcl	34	suppressed
Allopurinol	Allopurinol	33	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	33	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	33	14
Alendronate Sodium	Alendronate Sodium	32	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	32	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	32	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	31	suppressed
Risperidone	Risperidone	30	suppressed
Breo Ellipta	Fluticasone/Vilanterol	29	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	29	suppressed
Glipizide Er	Glipizide	28	suppressed
Propranolol Hcl	Propranolol Hcl	28	suppressed
Xarelto	Rivaroxaban	28	suppressed
Carvedilol	Carvedilol	27	suppressed
Divalproex Sodium	Divalproex Sodium	27	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	27	suppressed
Diazepam	Diazepam	26	suppressed
Nebivolol Hcl	Nebivolol Hcl	26	suppressed
Restasis	Cyclosporine	25	suppressed
Azelastine Hcl	Azelastine Hcl	24	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	23	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	23	13
Chlorhexidine Gluconate	Chlorhexidine Gluconate	22	suppressed
Folic Acid	Folic Acid	22	suppressed
Mometasone Furoate	Mometasone Furoate	22	13
Doxycycline Hyclate	Doxycycline Hyclate	21	19
Hydrocortisone	Hydrocortisone	21	suppressed
Januvia	Sitagliptin Phosphate	21	suppressed
Primidone	Primidone	21	suppressed
Amiodarone Hcl	Amiodarone Hcl	20	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	20	suppressed
Myrbetriq	Mirabegron	20	suppressed
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	20	suppressed
Azithromycin	Azithromycin	19	15
Fluoxetine Hcl	Fluoxetine Hcl	19	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	19	suppressed
Digoxin	Digoxin	18	suppressed
Irbesartan	Irbesartan	18	suppressed
Labetalol Hcl	Labetalol Hcl	18	suppressed
Neomycin-Polymyxin-Dexameth	Neomycin/Polymyxin B/Dexametha	18	suppressed
Fenofibrate	Fenofibrate	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Pyridostigmine Bromide	Pyridostigmine Bromide	17	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	17	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	17	suppressed
Clindamycin Phosphate	Clindamycin Phosphate	16	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	16	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	16	suppressed
Warfarin Sodium	Warfarin Sodium	16	suppressed
Telmisartan	Telmisartan	15	suppressed
Aripiprazole	Aripiprazole	14	suppressed
Ciloxan	Ciprofloxacin Hcl	14	suppressed
Midodrine Hcl	Midodrine Hcl	14	suppressed
Sildenafil Citrate	Sildenafil Citrate	14	suppressed
Benazepril Hcl	Benazepril Hcl	13	suppressed
Clobetasol Propionate	Clobetasol Propionate	13	12
Combigan	Brimonidine Tartrate/Timolol	13	suppressed
Cyclosporine	Cyclosporine	13	suppressed
Glipizide	Glipizide	13	suppressed
Lacosamide	Lacosamide	13	suppressed
Memantine Hcl Er	Memantine Hcl	13	suppressed
Namzaric	Memantine Hcl/Donepezil Hcl	13	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	13	suppressed
Solifenacin Succinate	Solifenacin Succinate	13	suppressed
Synthroid	Levothyroxine Sodium	13	suppressed
Alogliptin	Alogliptin Benzoate	12	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	12	suppressed
Loperamide	Loperamide Hcl	12	suppressed
Methotrexate	Methotrexate Sodium	12	suppressed
Octreotide Acetate	Octreotide Acetate	12	suppressed
Olanzapine	Olanzapine	12	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Vyvanse	Lisdexamfetamine Dimesylate	12	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	11
Eszopiclone	Eszopiclone	11	suppressed
Galantamine Hbr	Galantamine Hbr	11	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	11	suppressed
Mirabegron Er	Mirabegron	11	suppressed
Rytary	Carbidopa/Levodopa	11	suppressed
Xifaxan	Rifaximin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error